4MQB
Crystal structure of thymidylate kinase from staphylococcus aureus in complex with 2-(n-morpholino)ethanesulfonic acid
PDB DOI: 10.2210/pdb4mqb/pdb
Classification: TRANSFERASE Organism(s): Staphylococcus Aureus
Deposited: 2013-09-16 Deposition Author(s): Anderson, W.F. , Babnigg, G. , Filippova, E.V. , Jedrzejczak, R. , Joachimiak, A. , Kiryukhina, O. , Midwest Center For Structural Genomics (Mcsg) , Minasov, G. , Rubin, E. , Sacchettini, J. , Shuvalova, L. , Structures Of Mtb Proteins Conferring Susceptibility To Known Mtb Inhibitors (Mtbi)
Experimental Data Snapshot
Method: X-RAY DIFFRACTION Resolution: 1.55 Å
Crystal structure of thymidylate kinase from staphylococcus aureus in complex with 2-(n-morpholino)ethanesulfonic acid
Anderson, W.F. , Babnigg, G. , Filippova, E.V. , Jedrzejczak, R. , Joachimiak, A. , Kiryukhina, O. , Midwest Center For Structural Genomics (Mcsg) , Minasov, G. , Rubin, E. , Sacchettini, J. , Shuvalova, L. , Structures Of Mtb Proteins Conferring Susceptibility To Known Mtb Inhibitors (Mtbi)
Primary Citation of Related Structures: 4MQB
| Proteins | ||||
|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Sequence |
| Thymidylate kinase | A | 208 | Staphylococcus Aureus | SNAMSAFITFEGPEGSGKTTVINEVYHRLVKDYDVIMTREPGGVPTGEEIRKIVLEGNDMDIRTEAMLFAASRREHLVLKVIPALKEGKVVLCDRYIDSSLAYQGYARGIGVEEVRALNEFAINGLYPDLTIYLNVSAEVGRERIIKNSRDQNRLDQEDLKFHEKVIEGYQEIIHNESQRFKSVNADQPLENVVEDTYQTIIKYLEKI |
| Thymidylate kinase | B | 208 | Staphylococcus Aureus | SNAMSAFITFEGPEGSGKTTVINEVYHRLVKDYDVIMTREPGGVPTGEEIRKIVLEGNDMDIRTEAMLFAASRREHLVLKVIPALKEGKVVLCDRYIDSSLAYQGYARGIGVEEVRALNEFAINGLYPDLTIYLNVSAEVGRERIIKNSRDQNRLDQEDLKFHEKVIEGYQEIIHNESQRFKSVNADQPLENVVEDTYQTIIKYLEKI |
Experimental Data
Method: X-RAY DIFFRACTION
Deposited Date: 2013-09-16 Deposition Author(s): Anderson, W.F. , Babnigg, G. , Filippova, E.V. , Jedrzejczak, R. , Joachimiak, A. , Kiryukhina, O. , Midwest Center For Structural Genomics (Mcsg) , Minasov, G. , Rubin, E. , Sacchettini, J. , Shuvalova, L. , Structures Of Mtb Proteins Conferring Susceptibility To Known Mtb Inhibitors (Mtbi)